位置:首页 > 蛋白库 > LIMK1_DROME
LIMK1_DROME
ID   LIMK1_DROME             Reviewed;        1257 AA.
AC   Q8IR79; Q8IR78; Q9GV18; Q9GV19; Q9VYL6;
DT   22-NOV-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2003, sequence version 1.
DT   03-AUG-2022, entry version 162.
DE   RecName: Full=LIM domain kinase 1;
DE            Short=LIMK-1;
DE            EC=2.7.11.1 {ECO:0000269|PubMed:11027607};
DE   AltName: Full=dLIMK;
GN   Name=LIMK1; Synonyms=LIMK; ORFNames=CG1848;
OS   Drosophila melanogaster (Fruit fly).
OC   Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Hexapoda; Insecta; Pterygota;
OC   Neoptera; Endopterygota; Diptera; Brachycera; Muscomorpha; Ephydroidea;
OC   Drosophilidae; Drosophila; Sophophora.
OX   NCBI_TaxID=7227;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), FUNCTION, CATALYTIC
RP   ACTIVITY, SUBCELLULAR LOCATION, DEVELOPMENTAL STAGE, AND MUTAGENESIS OF
RP   ASP-522.
RX   PubMed=11027607; DOI=10.1006/bbrc.2000.3599;
RA   Ohashi K., Hosoya T., Takahashi K., Hing H., Mizuno K.;
RT   "A Drosophila homolog of LIM-kinase phosphorylates cofilin and induces
RT   actin cytoskeletal reorganization.";
RL   Biochem. Biophys. Res. Commun. 276:1178-1185(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Berkeley;
RX   PubMed=10731132; DOI=10.1126/science.287.5461.2185;
RA   Adams M.D., Celniker S.E., Holt R.A., Evans C.A., Gocayne J.D.,
RA   Amanatides P.G., Scherer S.E., Li P.W., Hoskins R.A., Galle R.F.,
RA   George R.A., Lewis S.E., Richards S., Ashburner M., Henderson S.N.,
RA   Sutton G.G., Wortman J.R., Yandell M.D., Zhang Q., Chen L.X., Brandon R.C.,
RA   Rogers Y.-H.C., Blazej R.G., Champe M., Pfeiffer B.D., Wan K.H., Doyle C.,
RA   Baxter E.G., Helt G., Nelson C.R., Miklos G.L.G., Abril J.F., Agbayani A.,
RA   An H.-J., Andrews-Pfannkoch C., Baldwin D., Ballew R.M., Basu A.,
RA   Baxendale J., Bayraktaroglu L., Beasley E.M., Beeson K.Y., Benos P.V.,
RA   Berman B.P., Bhandari D., Bolshakov S., Borkova D., Botchan M.R., Bouck J.,
RA   Brokstein P., Brottier P., Burtis K.C., Busam D.A., Butler H., Cadieu E.,
RA   Center A., Chandra I., Cherry J.M., Cawley S., Dahlke C., Davenport L.B.,
RA   Davies P., de Pablos B., Delcher A., Deng Z., Mays A.D., Dew I.,
RA   Dietz S.M., Dodson K., Doup L.E., Downes M., Dugan-Rocha S., Dunkov B.C.,
RA   Dunn P., Durbin K.J., Evangelista C.C., Ferraz C., Ferriera S.,
RA   Fleischmann W., Fosler C., Gabrielian A.E., Garg N.S., Gelbart W.M.,
RA   Glasser K., Glodek A., Gong F., Gorrell J.H., Gu Z., Guan P., Harris M.,
RA   Harris N.L., Harvey D.A., Heiman T.J., Hernandez J.R., Houck J., Hostin D.,
RA   Houston K.A., Howland T.J., Wei M.-H., Ibegwam C., Jalali M., Kalush F.,
RA   Karpen G.H., Ke Z., Kennison J.A., Ketchum K.A., Kimmel B.E., Kodira C.D.,
RA   Kraft C.L., Kravitz S., Kulp D., Lai Z., Lasko P., Lei Y., Levitsky A.A.,
RA   Li J.H., Li Z., Liang Y., Lin X., Liu X., Mattei B., McIntosh T.C.,
RA   McLeod M.P., McPherson D., Merkulov G., Milshina N.V., Mobarry C.,
RA   Morris J., Moshrefi A., Mount S.M., Moy M., Murphy B., Murphy L.,
RA   Muzny D.M., Nelson D.L., Nelson D.R., Nelson K.A., Nixon K., Nusskern D.R.,
RA   Pacleb J.M., Palazzolo M., Pittman G.S., Pan S., Pollard J., Puri V.,
RA   Reese M.G., Reinert K., Remington K., Saunders R.D.C., Scheeler F.,
RA   Shen H., Shue B.C., Siden-Kiamos I., Simpson M., Skupski M.P., Smith T.J.,
RA   Spier E., Spradling A.C., Stapleton M., Strong R., Sun E., Svirskas R.,
RA   Tector C., Turner R., Venter E., Wang A.H., Wang X., Wang Z.-Y.,
RA   Wassarman D.A., Weinstock G.M., Weissenbach J., Williams S.M., Woodage T.,
RA   Worley K.C., Wu D., Yang S., Yao Q.A., Ye J., Yeh R.-F., Zaveri J.S.,
RA   Zhan M., Zhang G., Zhao Q., Zheng L., Zheng X.H., Zhong F.N., Zhong W.,
RA   Zhou X., Zhu S.C., Zhu X., Smith H.O., Gibbs R.A., Myers E.W., Rubin G.M.,
RA   Venter J.C.;
RT   "The genome sequence of Drosophila melanogaster.";
RL   Science 287:2185-2195(2000).
RN   [3]
RP   GENOME REANNOTATION.
RC   STRAIN=Berkeley;
RX   PubMed=12537572; DOI=10.1186/gb-2002-3-12-research0083;
RA   Misra S., Crosby M.A., Mungall C.J., Matthews B.B., Campbell K.S.,
RA   Hradecky P., Huang Y., Kaminker J.S., Millburn G.H., Prochnik S.E.,
RA   Smith C.D., Tupy J.L., Whitfield E.J., Bayraktaroglu L., Berman B.P.,
RA   Bettencourt B.R., Celniker S.E., de Grey A.D.N.J., Drysdale R.A.,
RA   Harris N.L., Richter J., Russo S., Schroeder A.J., Shu S.Q., Stapleton M.,
RA   Yamada C., Ashburner M., Gelbart W.M., Rubin G.M., Lewis S.E.;
RT   "Annotation of the Drosophila melanogaster euchromatic genome: a systematic
RT   review.";
RL   Genome Biol. 3:RESEARCH0083.1-RESEARCH0083.22(2002).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   STRAIN=Berkeley; TISSUE=Embryo;
RX   PubMed=12537569; DOI=10.1186/gb-2002-3-12-research0080;
RA   Stapleton M., Carlson J.W., Brokstein P., Yu C., Champe M., George R.A.,
RA   Guarin H., Kronmiller B., Pacleb J.M., Park S., Wan K.H., Rubin G.M.,
RA   Celniker S.E.;
RT   "A Drosophila full-length cDNA resource.";
RL   Genome Biol. 3:RESEARCH0080.1-RESEARCH0080.8(2002).
RN   [5]
RP   FUNCTION, TISSUE SPECIFICITY, DEVELOPMENTAL STAGE, AND MUTAGENESIS OF
RP   ASP-522.
RX   PubMed=14972681; DOI=10.1016/j.cub.2004.01.056;
RA   Chen G.-C., Gajowniczek P., Settleman J.;
RT   "Rho-LIM kinase signaling regulates ecdysone-induced gene expression and
RT   morphogenesis during Drosophila metamorphosis.";
RL   Curr. Biol. 14:309-313(2004).
RN   [6]
RP   FUNCTION, INTERACTION WITH LATS1, SUBCELLULAR LOCATION, AND MUTAGENESIS OF
RP   ASP-522.
RX   PubMed=15220930; DOI=10.1038/ncb1140;
RA   Yang X., Yu K., Hao Y., Li D.-M., Stewart R.A., Insogna K.L., Xu T.;
RT   "LATS1 tumour suppressor affects cytokinesis by inhibiting LIMK1.";
RL   Nat. Cell Biol. 6:609-617(2004).
RN   [7]
RP   FUNCTION, AND MUTAGENESIS OF ASP-522.
RX   PubMed=15572110; DOI=10.1016/j.neuron.2004.11.014;
RA   Ng J., Luo L.;
RT   "Rho GTPases regulate axon growth through convergent and divergent
RT   signaling pathways.";
RL   Neuron 44:779-793(2004).
RN   [8]
RP   FUNCTION, AND MUTAGENESIS OF ASP-522.
RX   PubMed=15657426; DOI=10.1128/mcb.25.3.979-987.2005;
RA   Chen G.-C., Turano B., Ruest P.J., Hagel M., Settleman J., Thomas S.M.;
RT   "Regulation of Rho and Rac signaling to the actin cytoskeleton by paxillin
RT   during Drosophila development.";
RL   Mol. Cell. Biol. 25:979-987(2005).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1000, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY.
RX   PubMed=17372656; DOI=10.1039/b617545g;
RA   Bodenmiller B., Mueller L.N., Pedrioli P.G.A., Pflieger D., Juenger M.A.,
RA   Eng J.K., Aebersold R., Tao W.A.;
RT   "An integrated chemical, mass spectrometric and computational strategy for
RT   (quantitative) phosphoproteomics: application to Drosophila melanogaster
RT   Kc167 cells.";
RL   Mol. Biosyst. 3:275-286(2007).
CC   -!- FUNCTION: Protein kinase which regulates actin filament dynamics.
CC       Phosphorylates and inactivates the actin binding/depolymerizing factor
CC       tsr/cofilin, thereby stabilizing the actin cytoskeleton. Modulation of
CC       actin cytoskeleton dynamics may be essential for imaginal disk
CC       morphogenesis and axon guidance. {ECO:0000269|PubMed:11027607,
CC       ECO:0000269|PubMed:14972681, ECO:0000269|PubMed:15220930,
CC       ECO:0000269|PubMed:15572110, ECO:0000269|PubMed:15657426}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.1;
CC         Evidence={ECO:0000269|PubMed:11027607};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.1; Evidence={ECO:0000269|PubMed:11027607};
CC   -!- SUBUNIT: Interacts with LATS1, and this interaction inhibits
CC       phosphorylation of tsr/cofilin. {ECO:0000269|PubMed:15220930}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Cleavage furrow. Midbody.
CC       Note=Localizes to the cleavage furrow and the midbody at cytokinesis.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q8IR79-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8IR79-2; Sequence=VSP_016309;
CC       Name=3;
CC         IsoId=Q8IR79-3; Sequence=VSP_016308, VSP_016310;
CC   -!- TISSUE SPECIFICITY: Expressed throughout the imaginal disks of the eye,
CC       leg and wing. {ECO:0000269|PubMed:14972681}.
CC   -!- DEVELOPMENTAL STAGE: Expressed from early third instar to late pupal
CC       stages. {ECO:0000269|PubMed:11027607, ECO:0000269|PubMed:14972681}.
CC   -!- PTM: Phosphorylated on serine and/or threonine residues by ROCK1.
CC       Phosphorylated by PAK4 resulting in increased LIMK1 ability to
CC       phosphorylate cofilin. May be dephosphorylated and inactivated by SSH1
CC       (By similarity). {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. TKL Ser/Thr
CC       protein kinase family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB042816; BAB17233.1; -; mRNA.
DR   EMBL; AB042818; BAB17234.1; -; mRNA.
DR   EMBL; AE014298; AAF48176.2; -; Genomic_DNA.
DR   EMBL; AE014298; AAN09311.1; -; Genomic_DNA.
DR   EMBL; AE014298; AAN09312.1; -; Genomic_DNA.
DR   EMBL; AY119587; AAM50241.1; -; mRNA.
DR   RefSeq; NP_001162733.1; NM_001169262.1. [Q8IR79-2]
DR   RefSeq; NP_511139.2; NM_078584.3. [Q8IR79-1]
DR   RefSeq; NP_727621.1; NM_167326.2. [Q8IR79-2]
DR   RefSeq; NP_727622.1; NM_167327.2. [Q8IR79-3]
DR   AlphaFoldDB; Q8IR79; -.
DR   SMR; Q8IR79; -.
DR   BioGRID; 58605; 45.
DR   IntAct; Q8IR79; 9.
DR   STRING; 7227.FBpp0073493; -.
DR   iPTMnet; Q8IR79; -.
DR   PaxDb; Q8IR79; -.
DR   PRIDE; Q8IR79; -.
DR   DNASU; 32207; -.
DR   EnsemblMetazoa; FBtr0073659; FBpp0073492; FBgn0283712. [Q8IR79-2]
DR   EnsemblMetazoa; FBtr0073660; FBpp0073493; FBgn0283712. [Q8IR79-1]
DR   EnsemblMetazoa; FBtr0073661; FBpp0073494; FBgn0283712. [Q8IR79-3]
DR   EnsemblMetazoa; FBtr0301830; FBpp0291044; FBgn0283712. [Q8IR79-2]
DR   GeneID; 32207; -.
DR   KEGG; dme:Dmel_CG1848; -.
DR   CTD; 3984; -.
DR   FlyBase; FBgn0283712; LIMK1.
DR   VEuPathDB; VectorBase:FBgn0283712; -.
DR   eggNOG; KOG1187; Eukaryota.
DR   GeneTree; ENSGT00940000170287; -.
DR   InParanoid; Q8IR79; -.
DR   PhylomeDB; Q8IR79; -.
DR   Reactome; R-DME-2029482; Regulation of actin dynamics for phagocytic cup formation.
DR   Reactome; R-DME-399954; Sema3A PAK dependent Axon repulsion.
DR   Reactome; R-DME-5627123; RHO GTPases activate PAKs.
DR   GenomeRNAi; 32207; -.
DR   PRO; PR:Q8IR79; -.
DR   Proteomes; UP000000803; Chromosome X.
DR   Bgee; FBgn0283712; Expressed in brain and 22 other tissues.
DR   ExpressionAtlas; Q8IR79; baseline and differential.
DR   Genevisible; Q8IR79; DM.
DR   GO; GO:0032154; C:cleavage furrow; IEA:UniProtKB-SubCell.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0030496; C:midbody; IEA:UniProtKB-SubCell.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0106310; F:protein serine kinase activity; IEA:RHEA.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IBA:GO_Central.
DR   GO; GO:0030036; P:actin cytoskeleton organization; IDA:UniProtKB.
DR   GO; GO:0007560; P:imaginal disc morphogenesis; IMP:UniProtKB.
DR   GO; GO:0006468; P:protein phosphorylation; IEA:InterPro.
DR   Gene3D; 2.30.42.10; -; 1.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR001478; PDZ.
DR   InterPro; IPR036034; PDZ_sf.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR001781; Znf_LIM.
DR   Pfam; PF00412; LIM; 2.
DR   Pfam; PF00595; PDZ; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00132; LIM; 2.
DR   SUPFAM; SSF50156; SSF50156; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS00478; LIM_DOMAIN_1; 2.
DR   PROSITE; PS50023; LIM_DOMAIN_2; 2.
DR   PROSITE; PS50106; PDZ; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; ATP-binding; Cytoplasm; Kinase; LIM domain;
KW   Metal-binding; Nucleotide-binding; Phosphoprotein; Reference proteome;
KW   Repeat; Serine/threonine-protein kinase; Transferase; Zinc.
FT   CHAIN           1..1257
FT                   /note="LIM domain kinase 1"
FT                   /id="PRO_0000075808"
FT   DOMAIN          31..93
FT                   /note="LIM zinc-binding 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00125"
FT   DOMAIN          94..154
FT                   /note="LIM zinc-binding 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00125"
FT   DOMAIN          174..274
FT                   /note="PDZ"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00143"
FT   DOMAIN          401..686
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   REGION          1..147
FT                   /note="Interaction with LATS1"
FT                   /evidence="ECO:0000269|PubMed:15220930"
FT   REGION          1..24
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          552..587
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          759..811
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          881..900
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1010..1037
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1085..1182
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1212..1257
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        560..579
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        770..811
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1019..1037
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1085..1100
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1107..1175
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1221..1235
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        522
FT                   /evidence="ECO:0000250"
FT   BINDING         407..415
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         430
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   MOD_RES         1000
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:17372656"
FT   VAR_SEQ         1..205
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_016308"
FT   VAR_SEQ         203..225
FT                   /note="DLFCNFFLWLTSMAEQCCGAPYR -> E (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:11027607,
FT                   ECO:0000303|PubMed:12537569"
FT                   /id="VSP_016309"
FT   VAR_SEQ         206..225
FT                   /note="CNFFLWLTSMAEQCCGAPYR -> MSFWLHFVLKKILPWLKSTK (in
FT                   isoform 3)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_016310"
FT   MUTAGEN         522
FT                   /note="D->A: Abrogates kinase activity."
FT                   /evidence="ECO:0000269|PubMed:11027607,
FT                   ECO:0000269|PubMed:14972681, ECO:0000269|PubMed:15220930,
FT                   ECO:0000269|PubMed:15572110, ECO:0000269|PubMed:15657426"
FT   CONFLICT        613
FT                   /note="V -> L (in Ref. 1; BAB17233/BAB17234)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   1257 AA;  139304 MW;  3B3C988A69D07C69 CRC64;
     MHHQQRLRAN GGRGGTGLGA GSGPVSGGHS PLCAHCRGQL LPHPEEPIVM ALGQQWHCDC
     FRCSVCEGHL HNWYFEREGL LYCREDYYGR FGDACQQCMA VITGPVMVAG EHKFHPECFC
     CTACGSFIGE GESYALVERS KLYCGQCYGK RSCQPADAKA RITTAGKPMH SIRLVEIPKD
     ATPGLRVDGV ALDDGCPTVR ITDLFCNFFL WLTSMAEQCC GAPYRIDVNL TNLHIGDRIL
     EVNGTPVSDS SVEQIDKLIR SNEKMLQLTV EHDPVQVCRS CSQADIQRAM SASTLILPLS
     TSASSVEVGR ERLYKTPGEQ GTKARKLRQA TNASTTIPPA AGATAMTQLK EKERCSSLSK
     LLDEQHQAQQ HSAHPQLYDL SRTQSCRVVQ KPQRIFRATD LVIGEKLGEG FFGKVFKVTH
     RQSGEVMVLK ELHRADEEAQ RNFIKEVAVL RLLDHRHVLK FIGVLYKDKK LHMVTEYVAG
     GCLKELIHDP AQVLPWPQRV RLARDIACGM SYLHSMNIIH RDLNSMNCLV REDRSVIVAD
     FGLARSVDAP RLPSGNMTPG GYGSGANSDA PMSPSGTLRR SKSRQRRQRY TVVGNPYWMA
     PEMMKGLKYD EKVDVFSFGI MLCEIIGRVE ADPDFMPRNS DFSLNQQEFR EKFCAQCPEP
     FVKVAFVCCD LNPDMRPCFE TLHVWLQRLA DDLAADRVPP ERLLHEIETF QEWYASSEDA
     LSPTSQRSLN NLDELVKSAV DSEISPVEKE KENMVIKPQD IPKSPHLGKD FSPSGERLRD
     SMRARRRQRF LGAQEERRNL TPDTESKERA LKKALKKCRP FGERGYLVDL RAGAELQLED
     VRDLNTYSDV DSSCDTSLNY HDVNNLPAAQ EDENTVKPGK EELLEESTNK PSNQESQHHR
     LAIDDMRTRL NQCRSKFEHL EEASRRNFNQ SQHSMKNFFK TPPVALKMFQ RLEHEAAALN
     GGNNCPPPPP RTQRINQTPI FGRKNPPVAI VGQKLQHAES LEDLASSGVA KQLATPAPKR
     SKATATTKGG QSSNPPLFLP PSLNISVALN SNGNVTTTTN TNSSCPPSAS DWLPKKHKLT
     LPLPSAQQQR TSSNHRLPMC NNKGKTLKPL PSRTGSQGIP ASNCVSPTRS SRPGSPTKHL
     AQRHTAATAQ RLTNAAATHQ QQHQQQSSKT TRLNILSPEK VHRLGARLTD QKQKMREEAA
     ATASSVGGAG CAAGTAAGSL NGHRTIGSSG TPNSAVGERR RRAAPSPPVR THFNTRC
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024